Trial intelligence / Profile preview

Reparixin in Pancreatic Islet Transplantation

NCT01220856Phase 2Completed

Sponsor
Dompé
Start
Jul 2010
Primary completion
Apr 2013
Countries
2
01

Overview

A Phase 2 trial of reparixin in type 1 diabetes mellitus (T1D), sponsored by Dompé. Started Jul 2010; status: completed.

02

Drugs

reparixin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01220856.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01220856.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call